Company / Cost of Revenue
DarioHealth Corp. Cost of Revenue History
FY2014-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$3.9M
FY2018
5-year range
$0 / $3.9M
FY2014-FY2018
Trend
+14.7%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $2M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2018 with a 3-year CAGR of +19.3%.
Increased from $2M to $4M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +19.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +19.3%, indicating consistent growth.
- In FY2018, cost of revenue increased 14.7% year-over-year.
- Lowest cost of revenue in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $3.9M | +14.7% |
| FY2017 | $3.4M | +100.5% |
| FY2016 | $1.7M | -26.2% |
| FY2015 | $2.3M | - |
| FY2014 | $0 | - |
As of FY2018 · SEC 10-K Annual Filings · Updated Jun 24, 2026